日期 | 股东名称 | 披露原因 | 买入/卖出涉及 的股份数目 |
每股平均价 | 持有权益的 股份数目 |
占已发行 股本(%) |
12/01/2024 | UBS Group AG | 11033(L) | +29,652,439(L) | 534,997,450(L) 352,656,654(S) | 14.22 9.38 | |
12/01/2024 | LuYe Pharmaceutical International Co., Ltd. | 1101(L) | +2,000,000(L) | HKD3.311(L) | 1,259,196,703(L) 200,861,950(S) | 33.47 5.34 |
12/01/2024 | Nelumbo Investments Limited | 1101(L) | +2,000,000(L) | HKD3.311(L) | 1,259,196,703(L) 200,861,950(S) | 33.47 5.34 |
12/01/2024 | Ginkgo (PTC) Limited | 1101(L) | +2,000,000(L) | HKD3.311(L) | 1,259,196,703(L) 200,861,950(S) | 33.47 5.34 |
02/01/2024 | UBS Group AG | 1305(L) | 40,713,920(L) | 519,282,218(L) 357,339,116(S) | 13.80 9.50 | |
29/12/2023 | UBS Group AG | 10031(L) | +6,417,620(L) | 526,956,479(L) 358,242,254(S) | 14.01 9.52 | |
22/12/2023 | UBS Group AG | 1306(L) | 23,415,094(L) | 501,662,899(L) 354,629,754(S) | 13.34 9.43 | |
13/12/2023 | UBS Group AG | 1205(L) | -8,819,420(L) | 518,483,100(L) 354,993,254(S) | 13.78 9.44 | |
12/12/2023 | UBS Group AG | 11033(L) | +15,440,460(L) | 529,514,345(L) 357,462,754(S) | 14.08 9.50 | |
05/12/2023 | UBS Group AG | 1213(L) | -13,927,086(L) | 521,313,701(L) 355,415,254(S) | 10.81 9.45 | |
05/12/2023 | UBS Group AG | 1213(L) | -13,927,086(L) | 521,313,701(L) 355,415,254(S) | 13.86 9.45 | |
29/11/2023 | UBS Group AG | 1306(L) | 13,037,184(L) | 533,761,287(L) 355,543,254(S) | 14.19 9.45 | |
27/11/2023 | UBS Group AG | 1306(L) | 6,500,088(L) | 530,309,593(L) 355,691,254(S) | 14.10 9.46 | |
17/11/2023 | UBS Group AG | 1306(L) | 39,156,928(L) | 562,815,964(L) 356,213,270(S) | 14.96 9.47 | |
15/09/2023 | UBS Group AG | 1305(L) | 20,725,888(L) | 554,656,563(L) 353,531,802(S) | 14.74 9.40 | |
08/09/2023 | UBS Group AG | 1306(L) | 22,426,361(L) | 544,708,086(L) 352,073,362(S) | 14.48 9.36 | |
30/08/2023 | UBS Group AG | 1305(L) | 14,443,515(L) | 548,852,085(L) 357,588,293(S) | 14.59 9.51 | |
22/08/2023 | UBS Group AG | 1306(L) | 1,698,432(L) | 550,314,046(L) 352,834,793(S) | 14.63 9.38 | |
10/08/2023 | 易方达基金管理有限公司 | 1201(L) | -3,231,000(L) | HKD3.184(L) | 184,787,500(L) | 4.91 |
08/08/2023 | UBS Group AG | 1306(L) | 4,909,699(L) | 564,148,236(L) 363,783,388(S) | 14.99 9.67 | |
03/08/2023 | UBS Group AG | 1305(L) | 45,921,899(L) | 562,249,510(L) 363,580,867(S) | 14.95 9.67 | |
02/08/2023 | UBS Group AG | 12041(L) | -4,011,014(L) | 563,159,475(L) 364,864,831(S) | 14.97 9.70 | |
28/07/2023 | UBS Group AG | 1305(L) | 64,215,500(L) | 566,190,546(L) 364,884,603(S) | 15.05 9.70 | |
27/07/2023 | UBS Group AG | 1306(L) | 41,099,000(L) | 564,975,451(L) 364,525,808(S) | 15.02 9.69 | |
25/07/2023 | UBS Group AG | 1104(L) | +17,409,071(L) | 571,404,451(L) 362,611,293(S) | 15.19 9.64 | |
17/07/2023 | UBS Group AG | 1306(L) | 14,918,900(L) | 540,321,366(L) 362,538,347(S) | 14.36 9.64 | |
14/07/2023 | UBS Group AG | 1205(L) | -22,461,684(L) | 542,475,866(L) 362,538,383(S) | 14.42 9.64 | |
13/07/2023 | UBS Group AG | 1305(L) | 49,407,700(L) | 568,855,046(L) 365,216,941(S) | 15.12 9.71 | |
12/07/2023 | UBS Group AG | 1306(L) | 36,472,900(L) | 570,192,022(L) 367,413,806(S) | 15.16 9.77 | |
11/07/2023 | UBS Group AG | 1104(L) | +27,274,885(L) | 569,736,451(L) 367,391,174(S) | 15.15 9.77 | |
10/07/2023 | UBS Group AG | 1104(L) | +136,534,866(L) | 542,694,590(L) 367,512,793(S) | 14.43 9.77 | |
10/07/2023 | UBS Group AG | 1104(L) | +288,792,900(L) | 694,952,624(L) 367,512,793(S) | 18.47 9.77 | |
03/07/2023 | UBS Group AG | 1201(L) | -8,253,000(L) | HKD3.318(L) | 409,373,380(L) 372,451,793(S) | 10.88 9.90 |
30/06/2023 | 刘殿波 | 1313(L) | 218,500,000(L) | 1,257,196,703(L) 200,861,950(S) | 33.42 5.34 | |
30/06/2023 | UBS Group AG | 1201(L) | -68,750,000(L) | HKD3.535(L) | 414,017,118(L) 368,053,174(S) | 11.01 9.78 |
30/06/2023 | Shorea LBG | 1313(L) | 218,500,000(L) | 1,257,196,703(L) 200,861,950(S) | 33.42 5.34 | |
30/06/2023 | Ginkgo (PTC) Limited | 1313(L) | 218,500,000(L) | 1,257,196,703(L) 200,861,950(S) | 33.42 5.34 | |
30/06/2023 | Nelumbo Investments Limited | 1313(L) | 218,500,000(L) | 1,257,196,703(L) 200,861,950(S) | 33.42 5.34 | |
30/06/2023 | Luye Life Sciences Group Ltd | 1313(L) | 218,500,000(L) | 1,257,196,703(L) 200,861,950(S) | 33.42 5.34 | |
30/06/2023 | LuYe Pharmaceutical International Co., Ltd. | 1313(L) | 218,500,000(L) | 1,257,196,703(L) 200,861,950(S) | 33.42 5.34 | |
1 2 3 4 |
备注: | (L) - 长仓:包括 (1) 持有股份;(2) 透过持有丶沽出或发行金融合约,有权或有责任购买相关股份。 |
(S) - 短仓:包括 (1) 借入股份;(2) 透过持有丶沽出或发行金融合约,有权或有责任沽出相关股份。 | |
(P) - 可供借出的股份 | |
即时报价更新时间为 04/09/2024 10:27 | |
港股实时基本市场行情由香港交易所提供; 香港交易所指定免费发放实时基本市场行情的网站。 | |